Therapy of Diabetes Flashcards

1
Q

What is the leading cause of blindness and end-stage renal disease?

A

Diabetes Mellitus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the etiology of Type 1 Diabetes?

A

Autoimmune destruction of pancreatic β-cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the etiology of Type 2 Diabetes?

A

Insulin resistance. with inadequate β-cell function to compensate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Insulin levels in Type 1 Diabetes?

A

Absent or negligible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Insulin levels in Type 2 Diabetes?

A

Higher than normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Insulin action in Type 1 Diabetes?

A

Absent or negligible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Insulin action in Type 2 Diabetes?

A

Decreased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Is there insulin resistance in Type 1 Diabetes?

A

May be present if patient is obese

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Age of onset in Type 1 Diabetes?

A

<30 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Age of onset in Type 2 Diabetes?

A

> 40 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Acute complications of Type 1 Diabetes?

A

1) Ketoacidosis
2) Wasting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Acute complications of Type 2 Diabetes?

A

Hyperglycemia =
1) Hyperosmotic seizures
2) Coma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Chronic complications of Type 1 Diabetes?

A

1) Neuropathy
2) Retinopathy
3) Nephropathy
4) Peripheral vascular disease
5) Coronary artery disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Chronic complications of Type 2 Diabetes?

A

1) Neuropathy
2) Retinopathy
3) Nephropathy
4) Peripheral vascular disease
5) Coronary artery disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pharmacological intervention for Type 1 Diabetes?

A

Insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which drugs can cause diabetes?

A

1) Pyriminil (Vacor) (rodenticide)
2) Pentamidine
3) Nicotinic acid (Niacin) (B3)
4) Glucocorticoids
5) Thyroid hormones
6) Growth hormone
7) Diazoxide
8) β-adrenergic agonists
9) Thiazides
10) Interferon
11) Chronic alcoholism
12) Cyclosporine
13) HIV protease inhibitors
14) Atypical antipsychotics (clozapine and olanzapine)
15) Megestrol acetate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How does Pyriminil cause diabetes?

A

Loss of pancreatic β-cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How does Pentamidine cause diabetes?

A

Cytotoxic effect on pancreatic β-cells (type 1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How does Nicotinic acid (Niacin) cause diabetes?

A

Insulin resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How do Glucocorticoids cause diabetes?

A

1) Metabolic effects
2) Insulin antagonism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How do Thyroid hormones cause diabetes?

A

Increase hepatic glucose production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How does Growth hormone cause diabetes?

A

Reduces insulin sensitivity =
1) Mild hyperinsulinemia
2) Increased blood glucose levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

How does Diazoxide cause diabetes?

A

Inhibition of insulin secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How do β-adrenergic agonists cause diabetes?

A

1) Glycogenolysis
2) Gluconeogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

How do Thiazides cause diabetes?

A

Hypokalemia-induced inhibition of insulin release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

How does Interferon cause diabetes?

A

β-cell destruction (type 1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

How does chronic alcoholism cause diabetes?

A

1) Insulin insensitivity
2) Pancreatic β-cell dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

How does Cyclosporine cause diabetes?

A

1) Suppresses insulin production and release
2) Insulin resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

How do HIV protease inhibitors cause diabetes?

A

Insulin resistance with insulin deficiency relative to hyperglucagonemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

How do Atypical antipsychotics (clozapine and olanzapine) cause diabetes?

A

1) Weight gain
2) Insulin resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

How does Megestrol acetate cause diabetes?

A

Insulin resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

The primary goals of DM management are:

A

1) To reduce the risk of microvascular and macrovascular disease complications

2) To ameliorate symptoms

3) To reduce mortality

4) To improve quality of life

5) To minimize weight gain and hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Early diagnosis and treatment to near normoglycemia reduces the risk of developing:

A

Microvascular disease complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Retinopathy, nephropathy, and neuropathy are ___(macro/micro)-vascular complications.

A

Microvascular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What should you do to reduce the risk of developing macrovascular disease?

A

Aggressive management of cardiovascular risk factors:

1) Smoking cessation
2) Treatment of dyslipidemia
3) Intensive blood pressure control
4) Antiplatelet therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Ischemic heart disease, peripheral vascular disease, and cerebrovascular disease are ___(macro/micro)-vascular complications.

A

Macrovascular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

How does hyperglycemia contribute to poor wound healing?

A

By compromising white blood cell function and altering capillary function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Which severe manifestations of poor diabetes control always require hospitalization?

A

1) Diabetic ketoacidosis (DKA)
2) Hyperosmolar hyperglycemic state (HHS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

HbA1c goal for males and non-pregnant females?

A

<7% or <6.5% without significant
hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Critically ill (Hospital) glucose goal?

A

140-180 mg/dL, or down to 110-140mg/dL (without hypoglycemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

____ is recommended for all insulin resistant, overweight or obese individuals.

A

Weight reduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

What plans are available for medical nutrition therapy?

A

1) Low-carbohydrate, low-fat, calorie-restricted diets
2) Mediterranean diets rich in
mono-unsaturated fatty acids (olive oil)
3) Healthier eating behaviors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

In individuals with type 2 diabetes, ingested
protein appears to __(decrease/increase) insulin response without __(decreasing/increasing) plasma glucose concentrations.

A

Increase; Increasing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Should carbohydrate sources high in protein be used to treat or prevent hypoglycemia?

A

NO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Saturated fat should be ___ of total calories.

A

<7%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Avoid a high-protein diet in patients with:

A

Nephropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

How should physical activity goals be carried out?

A

At least 150min/wk of moderate intensity exercise spread over at least 3 days/week with no more than 2 days off between activities.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Resistance/Strength training is recommended at least 2 times a week in patients without:

A

1) Proliferative diabetic retinopathy
2) Ischemic heart disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

It is NOT appropriate to give patients with DM:

A

Brief instructions and a few pamphlets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

When should diabetes education occur?

A

1) At initial diagnosis
2) At ongoing intervals over a life-time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

You should emphasize that diabetic complications can be prevented or minimized with:

A

1) Good glycemic control
2) Managing risk factors for CVD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Blood pressure goals in diabetics?

A

<140/<90

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Initial drug therapy for hypertension in diabetics should be with:

A

ACEi or Angiotensin-receptor blocker (ARB)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

What lifestyle modifications should be done for dyslipidemia?

A

1) Reduction of saturated fat and cholesterol intake
2) Increasing omega-3 fatty acids intake
3) Use of viscous fiber and plant sterols
4) Weight loss
5) Increased physical activity
6) Statins (according to risk)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Use __ for secondary
cardioprotection in diabetics.

A

Aspirin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

How should insulin be given to critically ill (hospitalized) diabetics?

A

IV insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

How should insulin be given to non-critically ill diabetics?

A

Scheduled subcutaneous insulin with basal, nutritional, and correction coverage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

The aim of prevention of type 1 DM is:

A

To slow or stop its progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

What is Teplizumab?

A

A humanized monoclonal antibody to CD3 on T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Teplizumab is the first FDA approved drug that:

A

Mildly delays the onset of type 1 DM in patients 8 years of age or older with preclinical disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

The “4 life-style pillars” for the prevention of type 2 diabetes are to:

A

1) Decrease weight
2) Increase aerobic exercise
3) Increase fiber in diet
4) Decrease fat intake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Which drugs are used for preventing Diabetes Mellitus?

A

1) Metformin
2) Rosiglitazone
3) Acarbose
4) Liraglutide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Which drug reduces the RISK of
developing type 2 DM?

A

Metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

Which drug reduces the INCIDENCE of developing type 2 DM?

A

Rosiglitazone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

Which drugs reduce the PROGRESSION of developing type 2 DM?

A

1) Acarbose
2) Liraglutide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

Which DM patients always require insulin?

A

Type 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

Which insulin drugs are rapid acting?

A

1) Aspart
2) Lispro
3) Glulisine
4) Technosphere

68
Q

Which insulin drugs are short acting?

A

Regular insulin

69
Q

Which insulin drugs are intermediate acting?

A

NPH

70
Q

Which insulin drugs are long acting?

A

1) Detemir
2) Glargine
3) Degludec

71
Q

The simplest regimens that can approximate physiologic insulin release use:

A

“Split-mixed” injections

72
Q

What do “Split-mixed” injections consist of?

A

1) A morning dose of an intermediate-acting insulin (NPH)
2) A “bolus” rapid-acting insulin or regular insulin prior to the morning and evening meals

73
Q

In “Split-mixed” injections, the morning intermediate-acting insulin dose provides:

A

1) Basal insulin during the day
2) Prandial coverage for the midday meal

74
Q

In “Split-mixed” injections, morning intermediate-acting insulin dose provides:

A

Basal insulin throughout the evening and overnight

75
Q

When are “split-mixed” injections acceptable?

A

When patients have fixed timing of meals and carbohydrate intake.

76
Q

“Split-mixed” injections may NOT achieve good glycemic control overnight without causing:

A

Nocturnal hypoglycemia

77
Q

How can we reduce nocturnal hypoglycemia in “Split-mixed” injections?

A

Moving the evening NPH dose to bedtime

78
Q

Bolus or prandial insulin can be provided by either:

A

1) Regular insulin
2) Rapid-acting insulin analogs

79
Q

The rapid onset and short duration of action of ___ more closely replicate normal physiology than does ___.

A

The rapid-acting insulin analogs; Regular insulin

80
Q

Regular insulin is ___ insulin (____ insulin)

A

Soluble ;Crystalline zink

81
Q

What is the most sophisticated and precise method for insulin delivery?

A

Continuous subcutaneous insulin infusion (CS-II) or insulin pumps using a rapid-acting insulin

81
Q

Advantages of pairing Insulin pump therapy with Continuous glucose monitoring (CGM)?

A

1) Allows calculation of a correct insulin dose
2) Alerts the patient to hypoglycemia and hyperglycemia

81
Q

Insulin pump therapy may also be paired to ___.

A

Continuous glucose monitoring (CGM)

82
Q

Insulin pumps require ____ and ____ than does a basal-bolus multiple daily injections regimen.

A

Greater attention to details; More frequent self-monitored blood glucose (SMBG)

83
Q

Patients need ___ on how to use and maintain their Insulin pump.

A

Extensive training

84
Q

All patients treated with insulin should be instructed how to recognize and treat ___.

A

Hypoglycemia

85
Q

At each visit, patients with type 1 DM should be evaluated for __ including:

A

Hypoglycemia; The frequency and severity of hypoglycemic episodes

86
Q

Hypoglycemic unawareness may result from:

A

1) Autonomic neuropathy
2) Frequent episodes of hypoglycemia

87
Q

____ is a relative contraindication to continued intensive therapy.

A

The loss of warning signs of hypoglycemia

88
Q

Patients who have ___ despite proper insulin dose may benefit from addition of the
amylinomimetic pramlintide.

A

Erratic postprandial glycemic control

89
Q

___ suppresses endogenous production of glucose in the liver.

A

Amylin

90
Q

Is Pramlintide a substitute for bolus insulin?

A

NO

91
Q

Patients who have erratic postprandial glycemic control despite proper insulin dose may benefit from addition of the amylinomimetic ___.

A

Pramlintide

92
Q

Pramlintide __(can/can’t) be mixed with insulin.

A

Can’t

93
Q

When pramlintide is initiated, the dose of prandial insulin should be ____ to prevent hypoglycemia.

A

Reduced by 30 - 50%

94
Q

Effects of Pramlintide?

A

1) Slows gastric emptying mediated by the vagus nerve
2) Reduces glucagon secretion
3) Promotes satiety or reduces appetite - centrally
4) Produces moderate weight loss

95
Q

Slowed gastric emptying from Pramlintide is mediated by which nerve?

A

Vagus

96
Q

Adverse effects of Pramlintide?

A

1) Hypoglycemia
2) GIT disturbances
a) Nausea & Vomiting
b) Anorexia

97
Q

Patients with HbA1c ≤ 7.5% are usually treated with:

A

Metformin

98
Q

All patients with DM Type 2 should be treated with:

A

Therapeutic life-style modification

99
Q

Symptomatic DM Type 2 patients may initially require treatment with:

A

Insulin or combination therapy

100
Q

Patients with HbA1c > 7.5% but < 8.5% could be initially treated with:

A

1) A single agent
OR
2) Combination therapy

101
Q

Patients with > 8.5% HbA1c will require:

A

1) Two agents
OR
2) Insulin

102
Q

Obese patients without contraindications are often started on:

A

Metformin

103
Q

Contraindications to Metformin?

A

1) Renal dysfunction
2) Congestive cardiac failure
3) Metabolic acidosis
4) Impaired hepatic function

104
Q

Non-obese patients with Type 2 DM are more likely to be:

A

Insulinopenic

105
Q

Non-obese patients with Type 2 DM need medications that do what?

A

Increase insulin secretion

106
Q

Which medications are insulin secretagogues?

A

Sulfonylureas

107
Q

Sulfonylureas have several potential drawbacks, including:

A

1) Weight gain
2) Hypoglycemia

108
Q

Sulfonylureas may not be taken in patients with:

A

1) Liver disease
2) Kidney disease

109
Q

Do Sulfonylureas produce a durable glycemic response?

A

NO

110
Q

Which Sulfonylurea alternatives are better?

A

1) Dipeptidyl peptidase-4 inhibitors (DPP-4 inhibitors)
2) GLP-1 receptor agonists

111
Q

Do Thiazolidinediones (TZDs) produce a durable glycemic response?

A

Yes

112
Q

Why is Thiazolidinedione (TZDs) use limited?

A

Because they can cause:
1) Weight gain
2) Osteoporosis
3) Fluid retention
4) Risk of new onset heart failure

113
Q

Duration of action of Sulfonylureas?

A

24 hours (Give once daily)

114
Q

Duration of action of Non-sulfonyureas secretagogues?

A

2-3 hours

115
Q

Duration of action of Biguanides (Metformin)?

A

6-12 hours (Give 3 times)

116
Q

When do we reach the max effect of Thiazolidinediones?

A

4 weeks

117
Q

Duration of action of GLP-1 receptor agonists / Incretin mimetics?

A

10 hours or 24 hours (Depending on the drug)

118
Q

Duration of action of DPP-4 inhibitors?

A

24 hours (Once daily)

119
Q

Treatment selection for DM Type 2 should be based on multiple factors:

A

1) A patient who has had diabetes for several years, due to progressive failure of β-cell
function, is more likely to require insulin therapy

2) Multiple co-morbidities

3) If the patient’s fasting blood glucose readings are consistently elevated or only fluctuate postprandially.

4) Adverse effect profile

5) Contraindications

6) Hypoglycemia potential

7) Effect on body weight

8) Tolerability by the patient

9) Cost

10) Motivation

11) Resources

12) Potential difficulties with adherence

13) Older age

120
Q

What should you do if the patient’s postprandial blood glucose readings are the primary reason for poor control?

A

Pick a medication that addresses postprandial blood glucose fluctuations

121
Q

Which drugs are best for postprandial blood glucose regulation?

A

1) Glinides
2) α-glucosidase inhibitors

122
Q

Which combination therapy will help arrest β-cell failure?

A

Thiazolidinediones (TZDs) + GLP-1 receptor agonists

(Metformin + Pioglitazone + Exenatide)

123
Q

How do Thiazolidinediones help arrest β-cell failure?

A

By reducing apoptosis of β-cells

124
Q

How do GLP-1 receptor agonists help arrest β-cell failure?

A

By augmenting pancreatic function

125
Q

What does GLP-1 do?

A

1) Enhances insulin release in response to an ingested meal
2) Suppresses glucagon secretion
3) Delays gastric emptying
4) Decreases appetite

126
Q

What degrades GLP-1?

A

Dipeptidyl peptidase-4 (DPP-4)

127
Q

Which drugs are Glucagon-like peptide-1 agonists?

A

1) Exenatide
2) Liraglutide
3) Semaglutide

128
Q

Which GLP-1 agonist can be given orally?

A

Semaglutide

129
Q

What are Dual Agonists?

A

Drugs that activate both the Glucose-dependent Insulinotropic polypeptide (GIP) and GLP-1 receptors

130
Q

Which drug is a Dual Agonist?

A

Tirzepatide

131
Q

Which initial therapy is best for T2 DM with or at high risk for atherosclerotic cardiovascular disease?

A

GLP-1 receptor agonists, with or without metformin

132
Q

Which initial therapy is best for T2 DM without atherosclerotic cardiovascular disease?

A

Metformin

133
Q

Which is used as second or third line therapy for T2 DM without atherosclerotic cardiovascular disease?

A

GLP-1 receptor agonists

134
Q

Another use for GLP-1 receptor agonists and GIP/GLP-1 dual agonists?

A

Weight loss

135
Q

What are the most common adverse reactions to GLP-1 receptor agonists?

A

GI side effects

136
Q

Exenatide effects?

A

1) Delays gastric emptying
2) Suppresses postprandial glucagon release
3) Increases insulin secretion in a glucose dependent manner
4) Increases beta-cell mass, from decreased beta-cell apoptosis
5) May increase beta-cell formation
6) Suppresses appetite
7) Weight loss

137
Q

All adverse effects of Exenatide?

A

1) Nausea, vomiting, diarrhea
2) Acute pancreatitis
3) Renal impairment and acute renal injury

138
Q

Major adverse effect of Exenatide?

A

Nausea

139
Q

Is Exenatide’s major side effect dose or time dependent?

A

Dose-dependent

140
Q

Can Exenatide cause hypoglycemia?

A

No, unless combined with other drugs.

141
Q

How should insulinopenic patients with T2 DM be given meds?

A

1) Insulin injections at bedtime (intermediate- or long-acting basal insulin)

2) Oral agents or GLP-1 receptor agonists for control during the day

142
Q

Modification of therapy for insulinopenic T2 DM patients should depend on:

A

1) Fasting and posprandial glucose monitoring
2) HbA1c monitoring
3) Times of development of hypoglycemia

143
Q

DPP-4 are enzymes that degrade:

A

Incretin hormones

144
Q

Effects of DPP-4 Inhibitors?

A

1) Prolong the half-life of endogenous GLP-1
2) Decrease postprandial glucose levels
3) Decrease glucagon concentration
4) Increase circulating GLP-1 and GIP and thus, insulin concentrations in a glucose-dependent manner

145
Q

Which drugs are DPP-4 Inhibitors?

A

1) Sitagliptin
2) Saxagliptin
3) Linagliptin
4) Alogliptin

146
Q

Are DPP-4 Inhibitors given IV or orally?

A

Orally

147
Q

DPP-4 Inhibitors’ dosage should be reduced in patients with:

A

Impaired renal function

148
Q

Do DPP-4 Inhibitors reduce weight?

A

NO

149
Q

Adverse effects of DPP-4 Inhibitors?

A

1) Nasopharyngitis
2) URTIs
3) Headaches
4) Hypoglycemia when combined with insulin secretagogues or insulin.
5) Acute pancreatitis
6) Allergic reactions (Angioedema)
7) GIT: Nausea, diarrhea, and abdominal pain.

150
Q

What is the FDA warning on DPP-4 Inhibitors?

A

Increased heart failure risk and severe joint pain

151
Q

What is SGLT2?

A

The main transporter for glucose reabsorption in the proximal tubules (90%).

152
Q

Which drugs are SGLT2 Inhibitors?

A

1) Canagliflozin
2) Dapagliflozin

153
Q

How do SGLT2 Inhibitors decrease blood glucose levels?

A

By increasing urinary glucose loss

154
Q

SGLT2 inhibitors benefits?

A

1) Protects kidneys
2) Reduce risk of heart disease

155
Q

Mild adverse effects of SGLT2 inhibitors?

A

1) Thirst
2) Polyuria

156
Q

Severe adverse effects of SGLT2 inhibitors?

A

1) Increased incidence of UGS infections

2) Intravascular volume contraction and hypotension = osmotic diuresis

3) Decreased bone mineral density at the lumbar spine and the hip

4) Fractures due to osteoporosis and/or falls secondary to hypotension.

157
Q

What is the FDA warning on SGLT2 Inhibitors?

A

Increased incidence of UGS infections

158
Q

SGLT2 Inhibitors should not be used in patients prone to:

A

Diabetic ketoacidosis

159
Q

When T2DM adolescents’ glycemic goals can NOT be achieved or maintained with metformin and sulfonylurea, what should you give them?

A

Insulin

160
Q

Elderly patients may have an altered presentation of hypoglycemia because of:

A

Loss of autonomic nerve function with age

161
Q

Which drugs are best for T2 DM in the elderly?

A

1) DPP-4 inhibitors (Sitagliptin)
2) Shorter-acting insulin secretagogues (rapaglinide)
3) Low-dose sulfonylureas
4) α-glucosidase inhibitors

162
Q

DPP-4 inhibitors or α-glucosidase inhibitors have __(high/low) risk of hypoglycemia.

A

Low

163
Q

How should you treat Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic States?

A

Insulin given by continuous IV infusion

164
Q

It is important to stop which drug in all patients who arrive in acute care settings?

A

Metformin

165
Q

Metformin should be discontinued temporarily after any major surgery until it is clear that the patient:

A

1) Is hemodynamically stable
2) Has normal renal function